September 25, 2013
Information for Clinicians on the Latest in the Ground-Breaking Cancer Treatment Options that use the Power of the Immune System
Advanced Registration Extended until 12:00 pm CST on October 1, 2013
This program will provide clinical oncologists and the entire unit of care involved in treating cancer patients with an understanding of immunology principles related to the clinical application of immunotherapy agents, as well as basic and clinical immunology research and immunotherapy of malignancy.
Central themes in research advances and approvals will also be summarized to facilitate understanding of more sophisticated principles of tumor immunology and immunotherapy, and promote appropriate clinical application of cancer immunotherapies, how they work, their side effects and the efficacy to improve patient outcomes.
.jpg){kind=small}
Who should attend?
- Clinical Oncologists
- Oncology Nurses
- Medical Science Liaisons and Industry Representatives
- Government Representatives
- Medical Students and Early Career Scientists
- Allied Health Professionals
- Patients and Patient Advocates
- Individuals involved in the treatment of cancer or otherwise interested in cancer immunotherapy
Why should I attend?
- Earn CME-credits before the end of the year
- Interpret the key principles of tumor immunology and immunotherapy
- Explore the translation of cancer immunotherapy research into medical practice
- Analyze recent research and clinical applications of tumor immunization, immune coinhibition/costimulation, adoptive immunotherapy, and biomarkers
- Network and collaborate with local cancer immunotherapy experts in the field
What are the program topics and who are the speakers?
- Immunology 101 for the Practicing Oncologist
Charles Tannenbaum, PhD – Cleveland Clinic
- What You Need to Know about Innate Immunity
Jennifer S. Ko, MD, PhD – Cleveland Clinic
- Tumor Microenvironment: Hijacking the Immune System
James H. Finke, PhD – Cleveland Clinic
- Cytokine Therapy: Lessons Learned and Novel Agents
Pierre L. Triozzi, MD – Cleveland Clinic
- Therapeutic Cancer Vaccines: Successes and Failures in the Clinic
Joseph Baar, MD, PhD – Seidman Cancer Center
- Adoptive T cell Transfer as an Anti-tumor Approach
Gregory E. Plautz, MD – Cleveland Clinic
- Therapeutic Checkpoint Blockade
Brian I. Rini, MD – Cleveland Clinic
- Rationale for Combining Immunotherapy with Chemotherapy or Targeted Therapy
Qing Yi, MD, PhD – Cleveland Clinic
- Immunotherapy: The Need for Immune Monitoring and Development of Predictive Markers
Janis Taube, MD – Johns Hopkins School of Medicine
Where can I find more information?
- Visit: www.sitcancer.org/sitc-meetings/aci2013/aci13-oh for more information
- Can't make it to Cleveland? Click here to find more regional "Advances in Cancer Immunotherapy" program locations!
This program is jointly sponsored by Cleveland Clinic Foundation Center for Continuing Education and Society for Immunotherapy of Cancer
 |
 |
In collaboration with Case Comprehensive Cancer Center
 |
 |
This activity has been approved for AMA PRA Category 1 CreditTM.
